Research

At Albany we like to get involved with various research projects, we believe this is beneficial for everyone as it improves the chances of finding improved treatments for different illnesses. See below a few of the research programs we take part in.

The ERICA Trial

The earlier cancer is diagnosed, the better the outcome for the person. However, many types of cancer can be diagnosed too late – which is why a team led by researchers at the University of Exeter has developed new electronic risk assessment tools, called eRATs, to help GPs identify cancer in its earliest stages. These can be used alongside the clinical system the GP surgery normally uses.

The ERICA Study aims to look at the clinical effectiveness and cost-effectiveness of six of these eRATs (lung, oesopho-gastric, kidney, bladder, ovarian, and colorectal cancers). As a surgery, we are involved in a study comparing these electronic tools to normal clinical care.

As a patient, you will not need to sign up for this study, but anonymous information (information that cannot be used to identify you) from it will be gathered and assessed.

Want further information? (Click Here)

ATTACK Trial

Albany is involved in this research, led by the University of Southampton, to find out whether people with CKD (Chronic Kidney Disease) should take daily low-dose Aspirin to reduce their risk of a first heart attack or stroke.

Recruitment for this trial has been completed. Letters were sent to eligible patients, and if they had no contraindications, they were signed up to this study.

Want further information? (Click Here) or below.

Principle Trial

What is the Principle Trial?

The aim of this trial is to find treatments for COVID-19 for people in the community who are at higher risk of complications. We want to find medicines that can help people get better quickly and stop them needing to go to hospital.

This is a self-referral programme, if you are interested and fit the criteria see the below links.

Want further information? (Click Here) or below.